The link between COVID vaccine patents and fundamental uncertainty in financial markets: a post Keynesian analysis

Ömer Tuğsal Doruk

Journal of Post Keynesian Economics, 2025, vol. 48, issue 2, 358-373

Abstract: COVID-19 vaccines, developed rapidly and efficiently by pharmaceutical firms during the pandemic, serve as a focal point for this study. A novel framework is applied to examine the impact of patents on the corporate overvaluation of vaccine-producing firms. The findings indicate that, during the pandemic, patents contributed to the corporate overvaluation of these firms. These results provide new insights into the role of COVID-19 vaccine patents in driving corporate overvaluation, supporting the notion that post-Keynesian fundamental uncertainty led to “illusionist” financialization during the pandemic.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/01603477.2024.2444248 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mes:postke:v:48:y:2025:i:2:p:358-373

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/MPKE20

DOI: 10.1080/01603477.2024.2444248

Access Statistics for this article

More articles in Journal of Post Keynesian Economics from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().